|
Market Closed -
Nasdaq
08:00:00 14/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 22.83 USD | -4.99% |
|
-13.56% | -17.64% |
| 11/11 | Wedbush Raises Price Target on Beam Therapeutics to $33 From $30, Keeps Outperform Rating | MT |
| 11/11 | Beam Therapeutics Says Risto-Cel Meets Primary Endpoints in Sickle Cell Disease Trial | MT |
| Market Cap | 2.28B 2.06B 1.91B 1.72B 3.24B 215B 3.36B 22.91B 9.08B 115B 8.54B 8.36B 364B | P/E 2026 * |
-4.95x | P/E 2027 * | -4.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39B 1.26B 1.16B 1.05B 1.97B 131B 2.04B 13.95B 5.53B 69.77B 5.2B 5.09B 221B | EV / Sales 2026 * |
36x | EV / Sales 2027 * | 60.6x |
| Free-Float |
98.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BEAM | Delayed | |
CBOE
| BEAM | Real-time | |
|
Mexican S.E.
| BEAM * | End-of-day quote |
Last Transcript: Beam Therapeutics Inc.
| 1 day | -4.99% | ||
| 1 week | -13.56% | ||
| Current month | -16.16% | ||
| 1 month | -6.55% | ||
| 3 months | -13.88% | ||
| 6 months | -28.32% | ||
| Current year | -17.64% |
| 1 week | 22.81 |  | 27.39 |
| 1 month | 22.81 | | 29.76 |
| Current year | 21.63 | | 38.26 |
| 1 year | 20.23 | | 38.26 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 92.82 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 01/01/2017 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 19/12/2024 |
| President | 57 | 24/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 01/01/2017 |
Mark Fishman
BRD | Director/Board Member | 75 | 01/05/2018 |
Graham Cooper
BRD | Director/Board Member | 56 | 10/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/10/26 | Exercice | Chief Executive Officer | 75,000 | 0.0726% | ||
| 1/10/26 | Sell | Controller/Auditor | -187 | 0.0002% | ||
| 24/9/26 | Don | Chairperson | -123,407 | 0.1195% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.99% | -13.56% | +5.40% | +4.06% | 2.28B | |
| -2.69% | -0.48% | +51.67% | +69.09% | 66.33B | |
| -0.92% | +7.67% | +14.26% | +90.92% | 60.62B | |
| 0.00% | +0.39% | +20.52% | +98.45% | 55.5B | |
| +0.14% | +2.35% | +13.08% | +109.47% | 47.58B | |
| -2.21% | -2.47% | +18.60% | +36.89% | 43.69B | |
| -2.30% | -10.40% | +167.61% | +776.79% | 37.27B | |
| +2.15% | +1.42% | +15.17% | +56.49% | 36.57B | |
| -2.32% | -2.24% | +75.52% | +52.70% | 32.22B | |
| +2.62% | +5.90% | -36.55% | +406.95% | 26.58B | |
| Average | -1.05% | -1.31% | +34.53% | +170.18% | 41B | |
| Weighted average by Cap. | -0.85% | +0.12% | +37.05% | +161.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.51M 34.9M 32.28M 29.12M 54.88M 3.63B 56.82M 388M 154M 1.94B 145M 141M 6.16B | 31.22M 28.29M 26.17M 23.61M 44.49M 2.94B 46.06M 314M 125M 1.57B 117M 115M 4.99B |
| Net income | -480M -435M -403M -363M -685M -45.3B -709M -4.84B -1.92B -24.2B -1.8B -1.76B -76.82B | -561M -508M -470M -424M -800M -52.9B -828M -5.65B -2.24B -28.26B -2.11B -2.06B -89.7B |
| Net Debt | -890M -807M -746M -673M -1.27B -83.93B -1.31B -8.96B -3.55B -44.84B -3.34B -3.27B -142B | -382M -346M -320M -289M -545M -36.05B -564M -3.85B -1.53B -19.26B -1.43B -1.4B -61.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | USD 22.83 | -4.99% | 2,045,655 |
| 12/11/26 | USD 24.03 | -6.90% | 1,511,771 |
| 11/11/26 | USD 25.81 | +2.62% | 1,584,189 |
| 10/11/26 | USD 25.15 | -6.92% | 3,115,601 |
| 09/11/26 | USD 27.02 | +2.31% | 1,292,254 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
